A progenitor cell is a biological cell that, like a stem cell, has a tendency to differentiate into a specific type of cell, but is already more specific than a stem cell and is pushed to differentiate into its "target" cell. The most important difference between stem cells and progenitor cells is that stem cells can replicate indefinitely, whereas progenitor cells can divide only a limited number of times. Controversy about the exact definition remains and the concept is still evolving.
The terms "progenitor cell" and "stem cell" are sometimes equated.
Most progenitors are described as oligopotent. In this point of view, they may be compared to adult stem cells. But progenitors are said to be in a further stage of cell differentiation. They are in the "center" between stem cells and fully differentiated cells. The kind of potency they have depends on the type of their "parent" stem cell and also on their niche. Some progenitor cells were found during research, and were isolated. After their marker was found, it was proven that these progenitor cells could move through the body and migrate towards the tissue where they are needed. Many properties are shared by adult stem cells and progenitor cells.
Progenitor cells have become a hub for research on a few different fronts. Current research on progenitor cells focuses on two different applications: regenerative medicine and cancer biology. Research on regenerative medicine has focused on progenitor cells, and stem cells, because their cellular senescence contributes largely to the process of aging. Research on cancer biology focuses on the impact of progenitor cells on cancer responses, and the way that these cells tie into the immune response.
The natural aging of cells, called their cellular senescence, is one of the main contributors to aging on an organismal level. There are a few different ideas to the cause behind why aging happens on a cellular level. Telomere length has been shown to positively correlate to longevity. Increased circulation of progenitor cells in the body has also positively correlated to increased longevity and regenerative processes.Endothelial progenitor cells (EPCs) are one of the main focuses of this field. They are valuable cells because they directly precede endothelial cells, but have characteristics of stem cells. These cells can produce differentiated cells to replenish the supply lost in the natural process of aging, which makes them a target for aging therapy research. This field of regenerative medicine and aging research is still currently evolving.
Recent studies have shown that haematopoietic progenitor cells contribute to immune responses in the body. They have been shown to respond a range of inflammatory cytokines. They also contribute to fighting infections by providing a renewal of the depleted resources caused by the stress of an infection on the immune system. Inflammatory cytokines and other factors released during infections will activate haematopoietic progenitor cells to differentiate to replenish the lost resources.
The characterization or the defining principle of progenitor cells, in order to separate them from others, is based on the different cell markers rather than their morphological appearance.
Before embryonic day 40 (E40), progenitor cells generate other progenitor cells; after that period, progenitor cells produce only dissimilar mesenchymal stem cell daughters. The cells from a single progenitor cell form a proliferative unit that creates one cortical column; these columns contain a variety of neurons with different shapes.